Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels
Related Experiment Video
Updated: Aug 19, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
J M Romeo1, C Novo, A Fernández-Cruz
1Department of Surgery, Fundación Jimenez Diaz-Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Abstract:
Hepatic, splanchnic, and systemic hemodynamic effects of somatostatin infusion, as well as changes in plasma glucagon concentration, were studied in normal rats, using techniques involving radioactive microspheres and radioimmunoassay. Somatostatin infusion caused a decrease in arterial blood flow to the stomach, small intestine and spleen, with the net effect of reducing hepatic portal blood flow and portal pressure. The hepatic arterial blood flow was not altered. The systemic hemodynamic effects of somatostatin were slight, although renal blood flow diminished, Plasma glucagon concentration did not vary immediately after somatostatin infusion. The mechanism of the hemodynamic action of the hormone is not yet clear, but in normal conditions it is not related to the inhibition of glucagon secretion.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hypoglycemia and Glucagon

